C12N 7/025
Packaging cell lines
Official title: {Packaging cell lines, e.g. transcomplementing cell lines, for production of virus}
C12N7/025 (Packaging cell lines) appears on 21 US grants and 58 published applications in this corpus.
Search patents in C12N- Granted patents
- 21
- Published applications
- 58
- Assignees
- 37
- Inventors
- 124
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 0 |
| 2003 | 0 | 3 |
| 2004 | 0 | 0 |
| 2005 | 2 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 2 |
| 2013 | 3 | 3 |
| 2014 | 1 | 2 |
| 2015 | 1 | 1 |
| 2016 | 1 | 2 |
| 2017 | 1 | 1 |
| 2018 | 0 | 5 |
| 2019 | 0 | 4 |
| 2020 | 0 | 4 |
| 2021 | 1 | 2 |
| 2022 | 1 | 2 |
| 2023 | 1 | 3 |
| 2024 | 2 | 2 |
| 2025 | 2 | 1 |
| 2026 | 2 | 17 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Cell lines for production of adeno-associated virus9 Jun 2026US 12,649,908 B2The University of North Carolina at Chapel Hill
- Method for producing reassortant influenza viruses17 Mar 2026US 12,576,146 B2Seqirus UK Limited
- Methods and compositions for modified factor IX fusion proteins20 May 2025US 12,304,944 B2The University of North Carolina at Chapel Hill
- Recombinant adenoviruses carrying transgenes22 Apr 2025US 12,280,123 B2EpicentRx, Inc.
- Vero cell lines stably expressing HSV ICP0 protein24 Sep 2024US 12,098,380 B2The Brigham and Women S Hospital, Inc.
- Adenoviral vector vaccine, and preparation method and use thereof10 Sep 2026US 2026/0265702 A1Cansino Biologics Inc.
- Packaging plasmids for aav production3 Sep 2026US 2026/0258449 A1Biogen MA Inc.
- Method for production of virus-like particles for gene delivery27 Aug 2026US 2026/0250644 A1Carnegie Mellon University
- Recombinant retrovirus, compositions, and methods of use30 Jul 2026US 2026/0218136 A1Kelonia Therapeutics, Inc.
- Engineered nuclease with high salt tolerance30 Jul 2026US 2026/0218142 A1Wuxi Biologics Ireland Limited
Most cited
By later US patents
- Complementing cell lines58US 6,974,695 B2Crucell Holland B. V. · 2005
- Complementing cell lines49US 6,492,169 B1Crucell Holland B. V. · 2002
- Complementing cell lines24US 6,869,794 B2Crucell Holland B. V. · 2005
- Complementing cell lines6US 7,344,883 B2Crucell Holland B. V. · 2008
- Permissive cells and uses thereof5US 8,420,373 B2Universiteit Gent · 2013